Help shape the program and submit a session proposal to be considered by the program committee. Call for session suggestions have been extended from 31 January to 16 February 2018.
Click here to download the submission form.
The annual AusBiotech conference brings together Australian and international biotech leaders and stakeholders. For more than three decades, the event has created a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.
AusBiotech is dedicated to consolidating this growth, and our 2018 conference will once again present issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials and commercialisation.
The Millis Oration is named after Emertius Professor Nancy Millis (1922-2012), the First Lady of biotechnology.
One day investment event bringing world-leading biotech innovators together with Australia's early stage investment community to fund the future of life sciences. Featuring a mix of expert keynotes and life sciences company presentations, the event merges market intelligence with investment opportunities and will encourage successful biotech investment.
We gratefully acknowledge our session partners: